2017’s Ride for Helen promises to be one of the region’s biggest cycling event

14 Jan 2017’s Ride for Helen promises to be one of the region’s biggest cycling event

The fourth year of Ride for Helen, raising money for Helen Rollason Cancer Charity, promises to be one of the region’s biggest and best cycling events for 2017.

Thousands of cyclists from across the country will be meeting in Hatfield Peveral, Essex to take part in this fantastic, family-friendly event which offers a choice of four picturesque routes; six miles, 15 miles, 35 miles, or for the bravest of cyclists, 65 miles. All ages and abilities are welcome to join in as individuals or as a team, and families can enjoy two FREE child places for every paying adult on the six mile route.

Included in the registration price is a fundraising pack, route maps, full route signage, first aid support, mobile mechanic support and recovery, refreshment stops and a medal for finishers. Entrants have the option to purchase a Ride for Helen t-shirt on registration or a special cycling jersey which has been designed for the charity by Scrimitar (available to purchase from www.stores4sports.com).

This year’s fundraiser, which is sponsored by Essex Audi, has already been gaining lots of support from the charity’s well-known patrons, including Andrew Castle, Clare Balding and Sally Gunnell who will be wearing Ride for Helen t-shirts in the next few weeks.

HRCC Fundraising Manager Kate Alden says: “We’re so excited for this year’s Ride for Helen as it is always such an exciting and popular event and attracts a variety of participants, young and old. Last year, over 1100 cyclists took part, raising over £40,000 for Helen Rollason Cancer Charity. We have worked really hard to map out the best routes through the Essex countryside to ensure that all of our participants have a fantastic experience.”

The Helen Rollason Cancer Charity is dedicated to championing quality of life for everyone living with or affected by Cancer through the provision of free access support centres, complementary therapies, information and advice and supporting clinical trials.